Zheng Jing, Wen Yunxia, Song Yang, Wang Kai, Chen Dong-Bao, Magness Ronald R
Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Perinatal Research Laboratories, PAB1 Meriter Hospital, Madison, WI 53715, USA.
Biol Reprod. 2008 Jan;78(1):143-50. doi: 10.1095/biolreprod.107.064477. Epub 2007 Sep 26.
Fibroblast growth factor-2 (FGF2) and vascular endothelial growth factor (VEGF) are two key regulators of placental angiogenesis. The potent vasodilator nitric oxide (NO) could also act as a key mediator of FGF2- and VEGF-induced angiogenesis. However, the postreceptor signaling pathways governing these FGF2- and VEGF-induced placental angiogenic responses are poorly understood. In this study, we assessed the role of endogenous NO, mitogen-activated protein kinase 3/1 (MAPK3/1), and v-akt murine thymoma viral oncogene homolog 1 (AKT1) in FGF2- and VEGF-stimulated proliferation of ovine fetoplacental endothelial (OFPAE) cells. Both FGF2 and VEGF time-dependently stimulated (P < 0.05) NO production and activated AKT1. Both FGF2- and VEGF-stimulated cell proliferation was dose-dependently inhibited (P < 0.05) by N(G)-monomethyl-L-arginine (L-NMMA; an NO synthase inhibitor), PD98059 (a selective MAPK3/1 kinase 1 and 2 [MAP2K1/2] inhibitor), or LY294002 (a selective phosphatidylinositol 3 kinase [PI3K] inhibitor) but not by phenyl-4,4,5,5 tetramethylimidazoline-1-oxyl 3-oxide (PTIO, a potent extracellular NO scavenger). At the maximal inhibitory dose without cytotoxicity, PD98059 and LY294002 completely inhibited VEGF-induced cell proliferation but only partially attenuated (P < 0.05) FGF2-induced cell proliferation. PD98059 and LY294002 also inhibited (P < 0.05) FGF2- and VEGF-induced phosphorylation of MAPK3/1 and AKT1, respectively. L-NMMA did not significantly affect FGF2- and VEGF-induced phosphorylation of either MAPK3/1 or AKT1. Thus, in OFPAE cells, both FGF2- and VEGF-stimulated cell proliferation is partly mediated via NO as an intracellular and downstream signal of MAPK3/1 and AKT1 activation. Moreover, activation of both MAP2K1/2/MAPK3/1 and PI3K/AKT1 pathways is critical for FGF2-stimulated cell proliferation, whereas activation of either one pathway is sufficient for mediating the VEGF-induced maximal cell proliferation, indicating that these two kinase pathways differentially mediate the FGF2- and VEGF-stimulated OFPAE cell proliferation.
成纤维细胞生长因子2(FGF2)和血管内皮生长因子(VEGF)是胎盘血管生成的两个关键调节因子。强效血管舒张剂一氧化氮(NO)也可能是FGF2和VEGF诱导血管生成的关键介质。然而,调控这些FGF2和VEGF诱导的胎盘血管生成反应的受体后信号通路尚不清楚。在本研究中,我们评估了内源性NO、丝裂原活化蛋白激酶3/1(MAPK3/1)和v-akt小鼠胸腺瘤病毒癌基因同源物1(AKT1)在FGF2和VEGF刺激的绵羊胎儿胎盘内皮(OFPAE)细胞增殖中的作用。FGF2和VEGF均呈时间依赖性刺激(P<0.05)NO生成并激活AKT1。N(G)-单甲基-L-精氨酸(L-NMMA,一种一氧化氮合酶抑制剂)、PD98059(一种选择性MAPK3/1激酶1和2 [MAP2K1/2]抑制剂)或LY294002(一种选择性磷脂酰肌醇3激酶[PI3K]抑制剂)均剂量依赖性抑制(P<0.05)FGF2和VEGF刺激的细胞增殖,但苯基-4,4,5,5-四甲基咪唑啉-1-氧基3-氧化物(PTIO,一种有效的细胞外NO清除剂)则无此作用。在无细胞毒性的最大抑制剂量下,PD98059和LY294002完全抑制VEGF诱导的细胞增殖,但仅部分减弱(P<0.05)FGF2诱导的细胞增殖。PD98059和LY294002也分别抑制(P<0.05)FGF2和VEGF诱导的MAPK3/1和AKT1磷酸化。L-NMMA对FGF2和VEGF诱导的MAPK3/1或AKT1磷酸化均无显著影响。因此,在OFPAE细胞中,FGF2和VEGF刺激的细胞增殖均部分通过NO作为MAPK3/1和AKT1激活的细胞内和下游信号介导。此外,MAP2K1/2/MAPK3/1和PI3K/AKT1两条信号通路的激活对FGF2刺激的细胞增殖至关重要,而激活其中一条信号通路就足以介导VEGF诱导的最大细胞增殖,这表明这两条激酶信号通路在介导FGF2和VEGF刺激的OFPAE细胞增殖中存在差异。